Company profile

Amal Therapeutics SA

Amal Therapeutics SA, a spin-off from the University of Geneva, is developing new cancer vaccines, using with a proprietary family of vectors.

More news about Amal Therapeutics SA

28.06.2022 09:00

Three startups in the spotlight

Please login or
register to use the
awards follow feature
25.09.2020 11:30

Recognition for Swiss innovation

Please login or
register to use the
awards follow feature
03.08.2020 11:18

Female entrepreneurs in the spotlight

Please login or
register to use the
awards follow feature
16.07.2019 09:15

Amal Therapeutics becomes a subsidiary of a German Pharma giant

Please login or
register to use the
awards follow feature
03.05.2019 15:01

AMAL Therapeutics enters clinical collaboration with Boehringer Ingelheim

Please login or
register to use the
awards follow feature
12.11.2018 10:05

AMAL Therapeutics finalises CHF 33 million Series B round

Please login or
register to use the
awards follow feature
05.09.2017 11:45

AMAL Therapeutics raises CHF 8.8 million in Series B round

Please login or
register to use the
awards follow feature
14.09.2016 21:17

Top 100 Swiss startups have been revealed

Please login or
register to use the
awards follow feature
30.03.2016 09:24

Amal Therapeutics raises CHF 3 million in a Series A financing round

Please login or
register to use the
awards follow feature
24.03.2016 08:10

Amal Therapeutics receives CTI grant

Please login or
register to use the
awards follow feature
06.11.2015 13:42

11 start-ups selected for Swiss Venture Day Romandie

Please login or
register to use the
awards follow feature
28.08.2015 14:50

Start-ups selected for the 50th Swiss Venture Day

Please login or
register to use the
awards follow feature
29.06.2015 16:36

Amal achieves proof of concept

Please login or
register to use the
awards follow feature
17.04.2015 11:52

Nine hot start-ups, 400 visitors and Joe Jimenez

Please login or
register to use the
awards follow feature
09.07.2014 15:32

Amal Therapeutics SA announces appointment of Johanna Holldack as Chairman

Please login or
register to use the
awards follow feature
Amal Therapeutics SA

Founded
2012

Kanton
GE

Homepage

rss